Eton Pharmaceuticals Inc.

NASDAQ: ETON · Real-Time Price · USD
17.01
0.31 (1.86%)
At close: Aug 15, 2025, 3:59 PM
17.04
0.18%
After-hours: Aug 15, 2025, 04:10 PM EDT

Eton Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
14.94M 21.39M 16.3M 14.41M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
12K 12K 12K 21K
Receivables
5.36M 3.41M 1.85M 5.47M
Inventory
15.23M 911K 557K 550K
Other Current Assets
5.49M n/a n/a n/a
Total Current Assets
41.02M 26.84M 20M 23.6M
Property-Plant & Equipment
209K 150K 260K 219K
Goodwill & Intangibles
34.88M 4.74M 4.75M 3.62M
Total Long-Term Assets
35.1M 4.9M 5.03M 3.86M
Total Assets
76.12M 31.74M 25.03M 27.46M
Account Payables
4.17M 1.85M 1.77M 1.77M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a 5.38M 1.03M 1.42M
Other Current Liabilities
15.74M n/a n/a n/a
Total Current Liabilities
19.95M 16.24M 6.46M 4.56M
Long-Term Debt
29.81M n/a 5.38M 5.26M
Other Long-Term Liabilities
1.83M n/a n/a n/a
Total Long-Term Liabilities
31.75M 22K 5.49M 5.28M
Total Liabilities
51.7M 16.26M 11.95M 9.84M
Total Debt
29.92M 5.4M 6.52M 6.7M
Common Stock
27K 26K 25K 25K
Retained Earnings
-107.89M -104.07M -103.13M -94.11M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
24.43M 15.48M 13.08M 17.63M
Total Investments
n/a n/a n/a n/a